戻る Agenda
Session 9: Regulator Panel – Regional and Global Updates Part 2
Session Chair(s)
Renata De Lima Soares
Regulation and Health Surveillance Specialist
Anvisa, Brazil
Carla Chávez
Coordinadora de Seguridad y Eficacia
DIGEMID, Peru
This session is intended for each National Regulatory Authority (NRA) to provide a summary of the progress made on their regulatory projects as well as their priorities for 2021. Each NRA will have approximately 15-20 minutes to provide an update on progress made on several local, regional, and global projects as well as their priorities for the year that affect regulators and manufacturers/regulated sector in Latin America. A Q&A panel discussion will be held at the end of this session to provide any clarification where necessary.
Learning Objective : Upon completion of this session, the participant should be able to:
- Understand the progress made by NRAs in their projects
- Identify NRAs priorities for 2021
- Understand the impact of projects and priorities for regulators and manufacturers
Speaker(s)
Speaker
Giorgos Iliou
DINAVISA, Paraguay
Acting National Director of Health Surveillance
Speaker
Susan Zavala Coloma, MS, RPh
DIGEMID, Peru
Specialist, Sanitary Evaluation of Pharmaceutical Products, Biological Products
Speaker
Rian Marie Extavour, PhD, MSc, RPh
Caribbean Public Health Agency (CARPHA), Trinidad And Tobago
Programme Manager, Caribbean Regulatory System
Speaker
Nicole Ennis, MSc
Caribbean Public Health Agency, Jamaica
Head Medicines Quality Control and Surveillance Department
Speaker
Gustavo Mendes Lima Santos, MPharm
Brazilian Health Regulatory Agency (ANVISA), Brazil
Herbal and Complementary Medicines Office - GMESP